Related Experiment Video
Updated: Aug 9, 2025
07:41
Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
3.0K
Pathophysiology-Based Management of Acute Heart Failure
Luigi Falco1, Maria Luigia Martucci1, Fabio Valente1
1Heart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital Naples, 80131 Naples, Italy.
Clinics and Practice
|February 24, 2023
Summary
Acute heart failure (AHF) pathogenesis is unclear, hindering effective treatments. Understanding AHF pathophysiology and congestion is key to developing personalized therapies and improving patient outcomes.
Area of Science:
- Cardiology
- Internal Medicine
- Pathophysiology
Background:
- Acute heart failure (AHF) is a common global admission diagnosis.
- Current understanding of AHF pathogenesis remains limited, with few effective treatment options.
- Congestion is a primary driver of AHF hospitalizations and a critical therapeutic target.
Purpose of the Study:
- To review the pathophysiological principles underlying AHF clinical symptoms.
- To examine methods for assessing these pathophysiological principles in clinical practice.
- To advocate for a deeper understanding of AHF pathophysiology to guide personalized therapy.
Main Methods:
- Literature review focusing on AHF pathophysiology.
- Analysis of clinical assessment strategies for AHF.
- Synthesis of current knowledge to propose a pathophysiological-based therapeutic approach.
Main Results:
- AHF presents with heterogeneous onsets, but congestion is a universal feature.
- Reduced end-organ perfusion complicates complete decongestion in AHF patients.
- Current assessment methods for AHF pathophysiology require further refinement.
Conclusions:
- A comprehensive understanding of AHF pathophysiology is essential for effective treatment.
- Personalized, pathophysiology-based therapies hold promise for improving AHF management.
- Further research into AHF pathophysiological mechanisms can lead to significant therapeutic advancements.
Related Concept Videos
01:30Heart Failure V: Medical Management
19
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
01:17Pathophysiology of Heart Failure
1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
01:30Heart Failure VII: Nursing Interventions
130
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
130
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
479
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
479
01:29Heart Failure II: Pathophysiology
20
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
20
01:29Cardiomyopathy V: Interprofessional Care
22
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22